Johnson & Johnson (JNJ) Operating Expenses (2009 - 2026)

Johnson & Johnson's Operating Expenses history runs 18 years deep, the most recent figure standing at $9.6 billion for Q1 2026.

• In Q1 2026, Operating Expenses rose 14.83% year-over-year to $9.6 billion; the TTM figure through Mar 2026 stood at $25.3 billion (down 36.43% YoY), while the FY2025 annual figure was $24.0 billion, down 40.47% from the prior year.
• Operating Expenses came in at $9.6 billion for Q1 2026 at Johnson & Johnson, up from -$3.5 billion in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $11.8 billion in Q4 2024 to a low of -$10.6 billion in Q1 2022.
• A 5-year average of $6.6 billion and a median of $9.1 billion in 2023 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses slumped 261.96% in 2022 and jumped 377.09% in 2024, its largest moves.
• Johnson & Johnson's Operating Expenses stood at $8.5 billion in 2022, then tumbled by 149.92% to -$4.3 billion in 2023, then soared by 377.09% to $11.8 billion in 2024, then plunged by 129.4% to -$3.5 billion in 2025, then soared by 376.69% to $9.6 billion in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $9.6 billion, -$3.5 billion, and $9.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison